Lumos Pharma Inc (LUMO)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Lumos Pharma Inc Sees Remarkable 61.328% Jump in Revenue During Fourth Quarter of 2023
Lumos Pharma Inc. Reports Alarming Deficit Surge in Fiscal Year 2023
An Unusual Execution by Lumos Pharma Inc Shakes Up Q2 2023, Amidst Volatile Stock Performance
LUMO Shines Bright with Impressive Q1 Financial Performance
The company reported Revenue of $0.497 millions, in the most recent fiscal period
The company reported Revenue of $0.497 millions, in the Sep 30 2022 report
A loss of $-0.94 per Share at LUMO in the financial span ending June 30 2022
Lumos Pharma Inc announced Revenue of $0.111 million, in the first quarter of 2022